NCT04291560Completed
Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
The purpose of this trial is to determine whether a stretching intervention is superior to a usual care control condition (moderate/vigorous activity 30 minutes daily, 5 days per week) for pregnant women from 27 to 37 gestational weeks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 224 (actual)
- First submitted
- 21 Feb 2020
- Start date
- 1 Mar 2020
- Primary completion date
- 23 Oct 2024
- Lead sponsor
- University of North Carolina, Chapel Hill
- Diseases
- Obesity
- NCT number
- NCT04291560
What you commit to
- Study type: Interventional
- Participants enrolled: 224
- From 1 Mar 2020 to the primary completion date, 23 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Women who expect or are scheduled to deliver prior to 37 weeks gestation
Other
- Women who expect to move from the area during their participation in the study
- Women who are unable to exercise for 30 or more minutes 3 times per week
Who the study is looking for
- Pregnant at less than 24 weeks gestation
- Singleton pregnancy
- BMI ≥ 30 kg/m\^2 at their first prenatal care visit
- English or Spanish speaking
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of North Carolina at Chapel Hill Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.